Apotea AB (publ) (STO:APOTEA)

Chimerix Statistics

Total Valuation

Apotea AB has a market cap or net worth of SEK 11.79 billion. The enterprise value is 12.07 billion.

Market Cap	11.79B
Enterprise Value	12.07B

Important Dates

The last earnings date was Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Apotea AB has 104.07 million shares outstanding. The number of shares has increased by 1.57% in one year.

Current Share Class	104.07M
Shares Outstanding	104.07M
Shares Change (YoY)	+1.57%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	0.45%
Owned by Institutions (%)	56.82%
Float	73.29M

Valuation Ratios

The trailing PE ratio is 47.14 and the forward PE ratio is 43.15.

PE Ratio	47.14
Forward PE	43.15
PS Ratio	1.70
PB Ratio	15.15
P/TBV Ratio	16.56
P/FCF Ratio	74.71
P/OCF Ratio	31.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.23, with an EV/FCF ratio of 76.50.

EV / Earnings	48.42
EV / Sales	1.74
EV / EBITDA	26.23
EV / EBIT	38.07
EV / FCF	76.50

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.43.

Current Ratio	1.18
Quick Ratio	0.53
Debt / Equity	0.43
Debt / EBITDA	0.72
Debt / FCF	2.10
Interest Coverage	36.87

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	30.39%
Revenue Per Employee	9.56M
Profits Per Employee	343,388
Employee Count	800
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Apotea AB has paid 60.80 million in taxes.

Income Tax	60.80M
Effective Tax Rate	19.70%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	96.71
200-Day Moving Average	n/a
Relative Strength Index (RSI)	66.39
Average Volume (20 Days)	314,359

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Apotea AB had revenue of SEK 6.94 billion and earned 249.30 million in profits. Earnings per share was 2.40.

Revenue	6.94B
Gross Profit	1.91B
Operating Income	317.10M
Pretax Income	308.60M
Net Income	249.30M
EBITDA	400.25M
EBIT	317.10M
Earnings Per Share (EPS)	2.40

Balance Sheet

The company has 69.00 million in cash and 331.90 million in debt, giving a net cash position of -262.90 million or -2.53 per share.

Cash & Cash Equivalents	69.00M
Total Debt	331.90M
Net Cash	-262.90M
Net Cash Per Share	-2.53
Equity (Book Value)	778.20M
Book Value Per Share	7.29
Working Capital	171.00M

Cash Flow

In the last 12 months, operating cash flow was 371.90 million and capital expenditures -214.10 million, giving a free cash flow of 157.80 million.

Operating Cash Flow	371.90M
Capital Expenditures	-214.10M
Free Cash Flow	157.80M
FCF Per Share	1.52

Margins

Gross margin is 27.55%, with operating and profit margins of 4.57% and 3.59%.

Gross Margin	27.55%
Operating Margin	4.57%
Pretax Margin	4.44%
Profit Margin	3.59%
EBITDA Margin	5.76%
EBIT Margin	4.57%
FCF Margin	2.27%

Dividends & Yields

Apotea AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.57%
Shareholder Yield	n/a
Earnings Yield	2.11%
FCF Yield	1.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Apotea AB has an Altman Z-Score of 8.95 and a Piotroski F-Score of 5.

Altman Z-Score	8.95
Piotroski F-Score	5